Dipen J Parekh
#82,036
Most Influential Person Now
Dipen J Parekh's AcademicInfluence.com Rankings
Dipen J Parekhcomputer-science Degrees
Computer Science
#11360
World Rank
#12030
Historical Rank
Machine Learning
#5299
World Rank
#5366
Historical Rank
Artificial Intelligence
#5713
World Rank
#5796
Historical Rank
Database
#8602
World Rank
#9015
Historical Rank
Download Badge
Computer Science
Dipen J Parekh's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Dipen J Parekh Influential?
(Suggest an Edit or Addition)According to Wikipedia, Dipen J. Parekh is Chief Operating Officer at the University of Miami Health System, Chairman of Urology and the Dr. Victor Politano Endowed Chair in Clinical Urology at the Miller School of Medicine at University of Miami in Miami. He also serves as the Director of Robotic surgery at the University of Miami Health System . In 2012, he was awarded the American Urological Association Gold Cystoscope Award for his excellence in "establishing programs in urologic oncology and robotic surgery and outstanding contributions in transformative research".
Dipen J Parekh's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (2017) (1446)
- Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial (2018) (399)
- A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer. (2015) (314)
- Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. (2003) (268)
- Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy. (2013) (251)
- Tolerance of the human kidney to isolated controlled ischemia. (2013) (163)
- Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. (2005) (137)
- Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease. (2003) (134)
- Predicting prostate cancer risk through incorporation of prostate cancer gene 3. (2008) (124)
- External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population. (2006) (115)
- Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group (2011) (101)
- Biomarkers for prostate cancer detection. (2007) (97)
- Robotic Assisted Radical Cystectomy vs Open Radical Cystectomy: Systematic Review and Meta-Analysis (2019) (97)
- Continent urinary reconstruction versus ileal conduit: a contemporary single-institution comparison of perioperative morbidity and mortality. (2000) (95)
- The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group (2010) (92)
- Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. (2006) (90)
- Nox4 Mediates Renal Cell Carcinoma Cell Invasion through Hypoxia-Induced Interleukin 6- and 8- Production (2012) (88)
- Health‐related quality of life from a prospective randomised clinical trial of robot‐assisted laparoscopic vs open radical cystectomy (2014) (86)
- Definition, incidence, risk factors, and prevention of paralytic ileus following radical cystectomy: a systematic review. (2013) (81)
- Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies (2016) (81)
- The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update (2015) (74)
- microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion (2012) (73)
- Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group (2012) (69)
- Finding the Wolf in Sheep's Clothing: The 4Kscore Is a Novel Blood Test That Can Accurately Identify the Risk of Aggressive Prostate Cancer. (2015) (68)
- Current Paradigm for Ischemia in Kidney Surgery. (2016) (61)
- Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion (2011) (58)
- The 4Kscore® Test Reduces Prostate Biopsy Rates in Community and Academic Urology Practices. (2015) (53)
- Stabilization of HIF-2alpha through redox regulation of mTORC2 activation and initiation of mRNA translation (2012) (51)
- Re-examining Prostate-specific Antigen (PSA) Density: Defining the Optimal PSA Range and Patients for Using PSA Density to Predict Prostate Cancer Using Extended Template Biopsy. (2017) (51)
- Functional lower urinary tract voiding outcomes after cystectomy and orthotopic neobladder. (2000) (49)
- The use of radiography, urodynamic studies and cystoscopy in the evaluation of voiding dysfunction. (2001) (49)
- The role of hypercalciuria in a subgroup of dysfunctional voiding syndromes of childhood. (2000) (48)
- The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin. (2010) (48)
- Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder (2007) (47)
- Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. (2002) (46)
- Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk. (2003) (46)
- Utility and Validation of the AUA/SUO Risk Grouping for Non-muscle Invasive Bladder Cancer in a Contemporary Cohort. (2020) (45)
- Outcome of sibling vesicoureteral reflux. (2002) (44)
- Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions. (2002) (42)
- Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle‐invasive bladder cancer (2018) (40)
- Urinary diversion: options, patient selection, and outcomes. (2007) (39)
- Partial Gland Treatment of Prostate Cancer Using High‐Intensity Focused Ultrasound in the Primary and Salvage Settings: A Systematic Review (2017) (39)
- Biomarkers for prostate cancer detection (2010) (39)
- Prostate Artery Embolization in Patients with Prostate Volumes of 80 mL or More: A Single-Institution Retrospective Experience of 93 Patients. (2018) (38)
- Optical spectroscopy characteristics can differentiate benign and malignant renal tissues: a potentially useful modality. (2005) (38)
- Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy. (2000) (37)
- Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost‐effectiveness analysis (2013) (36)
- Efficacy of Prostatic Artery Embolization for Catheter-Dependent Patients with Large Prostate Sizes and High Comorbidity Scores. (2018) (35)
- Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group (2014) (35)
- Predictors of Recurrence, Progression-Free and Overall Survival Following Open Versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Follow-Up. (2020) (35)
- Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer (2018) (34)
- Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence. (2001) (32)
- Effect of matrix chemistry and WC types on the performance of Ni-WC based MMC overlays deposited by plasma transferred arc (PTA) welding (2017) (32)
- Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer. (2007) (32)
- Long‐term response to renal ischaemia in the human kidney after partial nephrectomy: results from a prospective clinical trial (2016) (31)
- Trends in Utilization of Robotic and Open Partial Nephrectomy for Management of cT1 Renal Masses. (2018) (30)
- The association of an increased urinary calcium-to-creatinine ratio, and asymptomatic gross and microscopic hematuria in children. (2002) (30)
- Assessment of 54 Biomarkers for Biopsy-Detectable Prostate Cancer (2007) (28)
- Ureteroneocystostomy without urethral catheterization shortens hospital stay without compromising postoperative success. (2003) (25)
- Association of Race and Ethnicity with COVID-19 Test Positivity and Hospitalization Is Mediated by Socioeconomic Factors (2021) (25)
- Yearly prostate specific antigen and digital rectal examination fluctuations in a screened population. (2009) (23)
- Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases (2019) (23)
- Development of a Nationally Representative Coordinated Registry Network for Prostate Ablation Technologies (2018) (22)
- Operative technique and early experience for robotic-assisted laparoscopic nephroureterectomy (RALNU) using da Vinci Xi (2015) (21)
- Health-Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial - A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical Cystectomy. (2020) (20)
- Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer. (2018) (20)
- A PROSPECTIVE, MULTICENTER, RANDOMIZED TRIAL OF OPEN VERSUS ROBOTIC RADICAL CYSTECTOMY (RAZOR): PNFLBA‐18 (2017) (19)
- Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL. (2007) (19)
- Kidney pericytes: a novel therapeutic target in interstitial fibrosis. (2012) (18)
- Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise (2015) (17)
- Robot‐assisted partial nephrectomy in cystic tumours: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI‐RUS) database (2016) (17)
- Outcomes of Laparoscopic and Robotic Partial Nephrectomy for Large (>4 Cm) Kidney Tumors: Systematic Review and Meta-Analysis (2017) (16)
- Robotic Partial Nephrectomy with the Da Vinci Xi (2016) (16)
- Contrast Intravasation During Hysterosalpingography (2016) (16)
- Surgical management of von Hippel-Lindau disease: urologic considerations. (2009) (14)
- The 4Kscore Predicts the Grade and Stage of Prostate Cancer in the Radical Prostatectomy Specimen: Results from a Multi-institutional Prospective Trial. (2017) (14)
- In vivo assessment of radio frequency induced thermal damage of kidney using optical spectroscopy. (2006) (14)
- Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy (2018) (14)
- Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study (2018) (13)
- A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry. (2018) (13)
- Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance (2015) (12)
- Does Every Minute of Renal Ischemia Still Count in 2019? Unlocking the Chains of a Flawed Thought Process over Five Decades. (2019) (12)
- Sociodemographic and survival disparities for histologic variants of bladder cancer. (2018) (12)
- The rapid uptake of robotic prostatectomy and its collateral effects (2012) (12)
- Is It Time to Revisit the Role of Prostate-specific Antigen Kinetics in Active Surveillance for Prostate Cancer? (2016) (12)
- The utility of 5-α reductase inhibitors in the prevention and diagnosis of prostate cancer (2009) (12)
- Reclassification Rates of Patients Eligible for Active Surveillance After the Addition of Magnetic Resonance Imaging-Ultrasound Fusion Biopsy: An Analysis of 7 Widely Used Eligibility Criteria. (2017) (11)
- Simplified laparoscopic radical cystectomy with orthotopic ileal neobladder creation in a porcine model. (2003) (11)
- Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer (2011) (11)
- Prospective Evaluation of Focal High-Intensity Focused Ultrasound (HIFU) for Patients with Localized Prostate Cancer. (2020) (10)
- Average Weight of Seminal Vesicles (2015) (10)
- Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy (2019) (10)
- Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder Cancer. (2019) (10)
- Predicting intra‐operative and postoperative consequential events using machine‐learning techniques in patients undergoing robot‐assisted partial nephrectomy: a Vattikuti Collective Quality Initiative database study (2020) (10)
- Re: Trends in Pelvic Lymphadenectomy at the Time of Radical Cystectomy: 1988 to 2004 (2009) (9)
- Using microscope for onco-testicular sperm extraction for bilateral testis tumors. (2018) (9)
- Entering an era of radiogenomics in prostate cancer risk stratification (2018) (9)
- Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies. (2007) (9)
- Can nomograms improve our ability to select candidates for active surveillance for prostate cancer? (2016) (9)
- The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality After Radical Prostatectomy in Hispanic or Latino Men: A Population-based Analysis. (2018) (9)
- Bloodstream Infection Risk, Incidence, and Deaths for Hospitalized Patients during Coronavirus Disease Pandemic (2021) (9)
- Primary neuroendocrine carcinoma of the urethra. (2002) (8)
- PROSTATIC DUCTAL ADENOCARCINOMA CONTROLLED FOR CANCER GRADE AND TUMOR VOLUME DOES NOT HAVE AN INDEPENDENT EFFECT ON ADVERSE RADICAL PROSTATECTOMY OUTCOMES COMPARED TO USUAL ACINAR PROSTATIC ADENOCARCINOMA. (2019) (7)
- Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. (2020) (7)
- Focal therapy for localized prostate cancer: Where do we stand? (2020) (7)
- Racial disparity and survival outcomes between African‐American and Caucasian American men with penile cancer (2018) (7)
- Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence (2022) (7)
- Timing of adjuvant chemotherapy and overall survival following radical cystectomy. (2019) (7)
- The Balance Between Open and Robotic Training Among Graduating Urology Residents: Does Surgical Technique Need Monitoring? (2019) (7)
- Malakoplakia of the prostate diagnosed on multiparametric-MRI ultrasound fusion guided biopsy: A case report and review of the literature (2017) (6)
- Comparison of perioperative outcomes following transperitoneal versus retroperitoneal robot-assisted partial nephrectomy: a propensity-matched analysis of VCQI database (2022) (6)
- Total prostate specific antigen stability confirmed after long-term storage of serum at -80C. (2008) (6)
- 594: Incidence and Predictors of Disease Outside a Modified Retroperitoneal Lymph Node Dissection Template in Clinical Stage (CS) I-IIA Nonseminomatous Germ Cell Testicular Cancer (2006) (6)
- Impact of Plant-Based Diet on PSA Level: Data from the National Health and Nutrition Examination Survey. (2021) (6)
- A Comprehensive Analysis of the Association Between Gleason Score at a Positive Surgical Margin and the Risk of Biochemical Recurrence After Radical Prostatectomy (2019) (6)
- Current Status of Nephron-Sparing Surgery (NSS) in the Management of Renal Tumours (2017) (5)
- Prediagnostic prostate‐specific antigen kinetics and the risk of biopsy progression in active surveillance patients (2016) (5)
- Predictive models and risk of biopsy progression in active surveillance patients. (2017) (5)
- Outcomes in robot‐assisted partial nephrectomy for imperative vs elective indications (2021) (5)
- Impact of Surgical Technique on Surgical Margin Status Following Partial Cystectomy. (2019) (5)
- Prevention and Treatment of Biopsy-Related Complications (2014) (5)
- Surveillance Intensity in Intermediate Risk Nonmuscle Invasive Bladder Cancer: Revisiting the Optimal Timing and Frequency of Cystoscopy. (2021) (5)
- 12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report. (2012) (4)
- Methods to Predict and Lower the Risk of Prostate Cancer (2011) (4)
- Current status of robotic and laparoscopic techniques in radical cystectomy and diversion procedures for bladder cancer: review. (2014) (4)
- Linking prediction models to government ordinances to support hospital operations during the COVID-19 pandemic (2021) (4)
- Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy. (2021) (3)
- Real world SARS-COV-2 vaccine effectiveness in a Miami academic institution (2022) (3)
- MP15-05 HEALTH RELATED QUALITY OF LIFE FROM A PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF ROBOTIC ASSISTED LAPAROSCOPIC VERSUS OPEN RADICAL CYSTECTOMY (2014) (3)
- A 4Kscore cut-off of 7.5% for prostate biopsy decisions provides high sensitivity and negative predictive value for significant prostate cancer. (2020) (3)
- Perioperative outcomes and complication predictors associated with open and minimally invasive nephroureterectomy. (2018) (3)
- The 4Kscore to predict the grade and stage of prostate cancer in the radical prostatectomy specimen: Results from a multi-institutional prospective trial. (2016) (3)
- Anterior or Posterior Prostate Cancer Tumor Nodule Location Predicts Likelihood of Certain Adverse Outcomes at Radical Prostatectomy. (2021) (3)
- Prostate cancer prevention with 5 alpha-reductase inhibitors. (2011) (3)
- A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System (2020) (3)
- Erratum: Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder (BJU International (2007) 99, 2, (281-285)) (2007) (2)
- Perioperative outcomes following robot-assisted partial nephrectomy for complex renal masses: A Vattikuti Collective Quality Initiative database study (2022) (2)
- Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis (2010) (2)
- Neoadjuvant vs adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysis. (2020) (2)
- Prostate Cancer Screening: Navigating the Controversy (2013) (2)
- Predictive Value of Sequential Organ Failure Assessment Score across Patients with and without COVID-19 Infection (2021) (2)
- Heterogeneity in Genomic Risk Assessment From Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of MRI Targeted Biopsy. (2020) (2)
- Propensity-matched analysis of stage-specific efficacy of adjuvant chemotherapy for bladder cancer. (2019) (2)
- Robot-assisted versus open cystectomy in the RAZOR trial – Authors' reply (2019) (2)
- Performance of multi-parametric MRI of the prostate in biopsy naïve men: A meta-analysis of prospective studies. (2020) (2)
- Surgery for Bladder and Upper Tract Urothelial Cancer. (2021) (2)
- Re: Use of 5a-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Kramer BS, Hagerty KL, Justman S, et al (2009) (2)
- Development and Validation of a Nomogram Predicting Intraoperative Adverse Events During Robot-assisted Partial Nephrectomy. (2022) (2)
- Preliminary results of perioperative outcomes and oncologic efficacy from a single-institution randomized controlled trial of open versus robotic-assisted radical cystectomy. (2012) (2)
- 433 Among men with low-grade prostate cancer on prostate biopsy, the 4Kscore predicts the presence of more aggressive prostate cancer (2015) (2)
- Perioperative outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial of Open Versus Robotic Assisted Radical Cystectomy. (2018) (1)
- MP77-20 AMONG MEN WITH LOW-GRADE PROSTATE CANCER ON PROSTATE BIOPSY, THE 4KSCORE PREDICTS MORE AGGRESSIVE PROSTATE CANCER AT PROSTATECTOMY. (2015) (1)
- Variance of Tumor Grade at Radical Prostatectomy With Assessment of Each Tumor Nodule Versus Global Grading. (2021) (1)
- Response of the human kidney to clamp ischemia. (2012) (1)
- Percentage of Gleason pattern 4 and tumor volume predict adverse pathological stage and margin status at radical prostatectomy in grade Group 2 and grade Group 3 prostate cancers (2021) (1)
- Perioperative outcomes following robot-assisted partial nephrectomy in elderly patients (2022) (1)
- LOCAL THERAPY IN METASTATIC PROSTATE CANCER: DOES THE BURDEN OF DISEASE MATTER? RESULTS FROM A NATIONAL POPULATION‐BASED CANCER REGISTRY: MP53‐15 (2017) (1)
- PD27-01 THE BALANCE BETWEEN OPEN AND ROBOTIC TRAINING AMONG GRADUATING UROLOGY RESIDENTS: SHOULD SURGICAL TECHNIQUE BE REGULATED? (2019) (1)
- CONTINENT URINARY RECONSTRUCTION VERSUS ILEAL CONDUIT: A CONTEMPORARY SINGLE INSTITUTION COMPARISON OF MORBIDITY (1999) (1)
- Defining the optimal PSA range for the maximal predictive efficacy of PSA density to detect prostate cancer on biopsy: Results from a multi-institutional and prospective contemporary cohort. (2016) (1)
- 847: Prospective Evaluation of P53 as a Prognostic Marker in T1 Transitional Cell Carcinoma (TCC) of the Bladder (2006) (1)
- Perioperative outcomes of open and minimally invasive nephroureterectomy and pre-operative predictors of complications: An analysis using the National Surgical Quality Improvement Program database. (2016) (1)
- 318 The performance of the 4Kscore for predicting high-grade cancer on biopsy of the prostate does not depend on the age of the patient (2015) (1)
- Active surveillance for favorable risk prostate cancer. Beware the risks. (2009) (1)
- A multi-institutional prospective trial in the United States to confirm the 4Kscore identification of men with high-grade prostate cancer. (2015) (1)
- Active surveillance: pitfalls to consider. (2011) (1)
- The clinical effectiveness of REGEN-COV in SARS-CoV-2 infection with Omicron versus Delta variants (2022) (1)
- Assessment of 54 biomarkers for biopsy-detectable prostate cancer (Cancer Epidemiology Biomarkers and Prevention (2007) 16, (1966-1972)) (2007) (1)
- Optical spectroscopy for guiding thermotherapies of tumors (2004) (1)
- Evidence trumps consensus (2019) (1)
- PD34-03 RACIAL DISPARITY IN THE UTILIZATION OF NEW THERAPIES FOR ADVANCED PROSTATE CANCER (2021) (1)
- Commentary on early hormonal therapy for PSA only recurrence after radical prostatectomy--success towards survival or antidote to anxiety? (2008) (1)
- Robot-assisted radical cystectomy versus open radical cystectomy (2018) (1)
- Preliminary results of perioperative outcomes and oncologic efficacy from a single-institution randomized controlled trial of open versus robotic-assisted radical cystectomy. (2012) (1)
- 933 PERIOPERATIVE OUTCOMES AND ONCOLOGICAL EFFICACY RESULTS OF A SINGLE-INSTITUTION RANDOMIZED CONTROLLED TRIAL OF OPEN VERSUS ROBOTIC RADICAL CYSTECTOMY FOR BLADDER CANCER (2011) (1)
- 412 Outcomes of robot-assisted partial nephrectomy in patients with complex renal tumours and pre-existing chronic kidney disease in a multi-institutional, multinational database (2016) (1)
- RE‐EXAMINING PSA DENSITY: DEFINING THE OPTIMAL PSA RANGE AND PATIENTS FOR USING PSA DENSITY TO PREDICT PROSTATE CANCER USING EXTENDED TEMPLATE BIOPSY: PD40‐02 (2017) (1)
- Warming up to ischemia. (2012) (1)
- MP06-20 APPLICATION OF AUA RISK STRATIFICATION FOR NON-MUSCLE INVASIVE BLADDER CANCER: LONG-TERM RESULTS IN A CONTEMPORARY SINGLE INSTITUTION COHORT (2018) (1)
- MP28-19 SETTING THE BAR: A 4KSCORE OF 7.5% PROVIDES HIGH SENSITIVITY AND NEGATIVE PREDICTIVE VALUE FOR DETECTING AND RULING OUT SIGNIFICANT PROSTATE CANCER (2019) (0)
- Corrigendum to “Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy” (2019) (0)
- MP61-09 PREDICTORS OF POSTOPERATIVE COMPLICATIONS AFTER ROBOTIC AND OPEN RADICAL CYSTECTOMY (2020) (0)
- MP08-09 NUTRITIONAL STATUS AND MAJOR ABDOMINAL SURGERIES: 30-DAY POSTOPERATIVE COMPLICATIONS (2016) (0)
- 381 The 4Kscore predicts the grade and stage of prostate cancer in the radical prostatectomy specimen: Results from a multi-institutional prospective trial (2016) (0)
- High-Intensity Focused Ultrasound (HIFU) Options for High-Risk Prostate Cancer (2018) (0)
- Screening for aggressive prostate cancer: A single-center experience using the 4Kscore and multiparametric MRI for the detection of Gleason 7 or higher prostate cancer. (2017) (0)
- PD48-02 PERIOPERATIVE OUTCOMES OF OPEN AND MINIMALLY INVASIVE NEPHROURETERECTOMY AND PRE-OPERATIVE PREDICTORS OF COMPLICATIONS: AN ANALYSIS USING THE NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM DATABASE. (2016) (0)
- Response of the human kidney to clamp ischemia. (2012) (0)
- Editorial: Impact of coronavirus disease 2019 on urological healthcare (2022) (0)
- 923 Impact of annual surgical volume on outcomes of robot-assisted partial nephrectomy in a multi-institutional, multinational cohort (2015) (0)
- Among men with low-grade prostate cancer on prostate biopsy, the 4Kscore to predict prostate cancer aggressiveness at prostatectomy. (2016) (0)
- 409 Preoperative predictors of renal failure after robot-assisted partial nephrectomy: Analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database (2016) (0)
- MP55-05 BASELINE 4K SCORE PREDICTS PROGRESSION ON ACTIVE SURVEILLANCE IN PROSTATE CANCER INDEPENDENTLY OF CLINICAL INFORMATION AND PIRADS SCORE (2023) (0)
- Cancer detection between peripheral zone and transitional zone targeted biopsies: Preliminary results from a prospective cohort of men undergoing MRI-US fusion biopsy. (2016) (0)
- LYMPH NODE YIELD AS A PREDICTOR OF OVERALL SURVIVAL FOLLOWING REGIONAL LYMPHADENECTOMY FOR PENILE CANCER: MP80‐14 (2017) (0)
- Successful management of renal leiomyosarcoma using radiofrequency ablation: Case report and brief review of literature (2014) (0)
- Role of non-neoplastic renal parenchyma abnormalities in the population with preoperative CKD. (2016) (0)
- 3:16 PM Abstract No. 5 Clinical outcomes measures in the use of prostate artery embolization for prostates ≥80 grams: a single-center experience in 110 patients (2018) (0)
- Trends in outpatient versus inpatient urologic surgery at a university academic medical center (2022) (0)
- PD10-11 COMPARISON OF SURVIVAL OUTCOMES FOR AFRICAN-AMERICAN AND CAUCASIAN MEN WITH ADVANCED PENILE CANCER IN FLORIDA (2016) (0)
- PD29-04 PREDICTORS OF DEEP INCISIONAL AND ORGAN/SPACE SURGICAL SITE INFECTION FOLLOWING RADICAL CYSTECTOMY: RESULTS FROM THE ACS NSQIP SURGICAL REGISTRY (2023) (0)
- Words of wisdom. Re: Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. Hellenthal NJ, Ramirez ML, Evans CP, deVere White RW, Koppie TM. (2009) (0)
- Prostate cancer upgrading and adverse pathology in Hispanic men undergoing radical prostatectomy (2022) (0)
- First major study comparing robotic to open surgery published in The Lancet (2021) (0)
- Atypical ATMs: Broadening the phenotypic spectrum of ATM-associated hereditary cancer (2023) (0)
- Rise of robotics in urologic surgery: current status and future directions (2013) (0)
- THE 4KSCORE TEST ACCURATELY PREDICTS AGGRESSIVE PROSTATE CANCER IN MEN OF ALL AGES AND RACE: PD07‐01 (2017) (0)
- MP67-10 CLINICAL FACTORS ASSOCIATED WITH EARLY RETURN OF URINARY CONTROL FOLLOWING RETZIUS-SPARING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY (2023) (0)
- Reply by Authors. (2021) (0)
- A prospective trial assessing the effects of clamp ischemia during partial nephrectomy on renal function, biomarkers, and structure. (2012) (0)
- Focal therapy for localized prostate cancer – Current status (2022) (0)
- 474: Detection of Radiofrequencyablation Induced Thermal Damage Using Optical Spectroscopy (2004) (0)
- PD52-11 HEALTH RELATED QUALITY OF LIFE OUTCOMES BY URINARY DIVERSION: AN ANALYSIS FROM THE RANDOMIZED ROBOTIC VERSUS OPEN RADICAL CYSTECTOMY (RAZOR) TRIAL (2019) (0)
- 921 Perioperative and functional outcomes of robot-assisted partial nephrectomy for renal tumors >4 cm in a multi-institutional, multinational cohort (2015) (0)
- V11-09 USING MICROSCOPE FOR ONCO-TESTICULAR SPERM EXTRACTION FOR BILATERAL TESTIS TUMORS (2018) (0)
- Does variation in prostate volume calculated with MRI versus TRUS lead to reclassification of men based on current PSA density threshold for active surveillance criteria? Result from a prospective cohort. (2016) (0)
- Editorial Comment. (2018) (0)
- 1016 Are continent urinary diversions feasible at the time of radical cystectomy after pelvic radiotherapy? Analysis of a large retrospective multicenter series (2016) (0)
- Chemoprevention of Prostate Cancer (2010) (0)
- MP69-07 IMPACT OF PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY ON 30-DAY POST OPERATIVE COMPLICATIONS: RESULTS FROM A LARGE NATIONAL DATABASE (2016) (0)
- Can PSA density and free-to-total PSA ratio improve our ability to predict prostate cancer on biopsy? Results from a prospective, multi-institutional, and contemporary cohort. (2016) (0)
- Robotic assisted radical cystectomy and urinary diversion (2015) (0)
- V05-02 USE OF CIRCULAR NEPHROTOMY IN ROBOTIC PARTIAL NEPHRECTOMY: A BEFITTING REPLY IN SELECT CASES OF COMPLEX RENAL MASS (2023) (0)
- Table of Contents (2016) (0)
- MP60-06 THE PERFORMANCE OF THE 4KSCORE FOR PREDICTING HIGH-GRADE CANCER ON BIOPSY OF THE PROSTATE DOES NOT DEPEND ON THE AGE OF THE PATIENT (2015) (0)
- 460 CONCURRENT METABOLIC AND TRANSCRIPTOMIC ANALYSIS OF CLEAR CELL RENAL CANCER (2013) (0)
- Abstract #4401: p22phox-dependent regulation of tuberin function in RCC: role of ERK and Akt pathways (2009) (0)
- Open Radical Cystectomy (2015) (0)
- Association of care by a non-medical intensive care unit provider team with outcomes of medically critically ill patients. (2022) (0)
- MP62-19 THE PERFORMANCE OF MPMRI AND THE 4KSCORE FOR PREDICTING PROGRESSION ON ACTIVE SURVEILLANCE: RESULTS FROM A SINGLE INSTITUTION PROSPECTIVE STUDY (2021) (0)
- UTILIZATION OF ROBOTIC VERSUS OPEN PARTIAL NEPHRECTOMY FOR MANAGEMENT OF CT1 AND CT2 RENAL MASSES: PD66‐09 (2017) (0)
- PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES (2016) (0)
- Off-clamp versus on-clamp robot-assisted partial nephrectomy: A propensity-matched analysis (2023) (0)
- Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study (2018) (0)
- Impact of pelvic lymph node dissection during radical prostatectomy on 30-day post operative complications: Results from a large national database. (2016) (0)
- ROBOTIC ASSISTED LAPAROSCOPIC CYSTOPROSTATECTOMY WITH EXTENDED PELVIC LYMPH NODE DISSECTION (2008) (0)
- 3:08 PM Abstract No. 4 Treating refractory hematuria of prostatic origin with prostate artery embolization: single-institution experience in 12 patients (2018) (0)
- PD13-05 ANDROGEN SUPPRESSION THERAPY IS ASSOCIATED WITH LOWER RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER (2019) (0)
- A ROBOTIC URETERONEOCYSTOTOMY FOR A DISTAL URETERAL STRICTURE (2008) (0)
- Integration of Risk Assessment in Prostate Cancer Screening (2009) (0)
- Editorial comment. (2011) (0)
- MP75-16 OUTCOMES OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY IN PATIENTS WITH COMPLEX RENAL TUMORS AND PRE-EXISTING CHRONIC KIDNEY DISEASE: A MULTI-INSTITUTIONAL ANALYSIS (2016) (0)
- COMPARISON OF READMISSION AND SHORT‐TERM MORTALITY RATES BETWEEN DIFFERENT TYPES OF URINARY DIVERSION IN PATIENTS UNDERGOING RADICAL CYSTECTOMY: MP54‐11 (2017) (0)
- A CASE-CONTROL STUDY OF FIFTY-FOUR BIOMARKERS OF PROSTATE CANCER (2008) (0)
- PD38-03 THE 4KSCORE IS ASSOCIATED WITH MORE ADVANCED DISEASE AT RADICAL PROSTATECTOMY; RESULTS FROM A MULTI-INSTITUTIONAL PROSPECTIVE TRIAL. (2015) (0)
- 242 Comparison of survival outcomes for African-American and Caucasian men with advanced penile cancer in Florida (2016) (0)
- Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: No. (2017) (0)
- MP68-12 PREDICTING INTRAOPERATIVE COMPLICATIONS AND 30-DAYS MORBIDITY USING MACHINE LEARNING TECHNIQUES FOR PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (2020) (0)
- 397 HYPOXIA INDUCES NOX-DEPENDENT ACTIVATION OF NFKB AND SECRETION OF IL-6 AND IL-8 IN RENAL CELL CARCINOMA (2011) (0)
- MP61-14 READMISSION RATES AND THEIR PREDICTORS AFTER ROBOTIC AND OPEN RADICAL CYSTECTOMY (2020) (0)
- 620 Complication rates after radical cystectomy following any previous abdominal-pelvic-perineal radiotherapy: An international, multicenter retrospective study on 609 cases (2016) (0)
- IS AN UPGRADED PIRADS 4 EQUIVALENT TO A TRUE PIRADS 4? A VALIDATION OF PIRADS VERSION 2 IN A PROSPECTIVE COHORT OF MEN UNDERGOING MRI‐US FUSION BIOPSY OF THE PROSTATE: MP38‐04 (2017) (0)
- PD02-04 TOP-HEAVY TRAINING: TRENDS IN UROLOGY RESIDENT EXPOSURE TO MAJOR SURGERY (2021) (0)
- MP21-18 PROSTATE CANCER DETECTION BETWEEN PERIPHERAL ZONE AND TRANSITIONAL ZONE TARGETED BIOPSIES: PRELIMINARY RESULTS FROM A PROSPECTIVE COHORT OF MEN UNDERGOING MRI-US FUSION BIOPSY (2016) (0)
- Clinical Cancer esearch an Cancer Biology Relationship between Prostate-Specific Antigen and state Cancer Risk : The Prostate Biopsy R laborative Group (2010) (0)
- Reply by Authors. (2019) (0)
- SMOKING INTENSITY AS A PREDICTOR OF SURVIVAL IN BLADDER CANCER PATIENTS: RESULTS FROM A POPULATION‐BASED FLORIDA CANCER REGISTRY (1981‐2009): MP04‐18 (2017) (0)
- Validation of dominant and secondary sequence utilization in PI-RADS v2 for classifying prostatic lesions. (2019) (0)
- Prostate cancer: Treatment triggers for patients on active surveillance (2011) (0)
- ROBOTIC ASSISTED LAPAROSCOPIC ADRENALECTOMY (2009) (0)
- PD60-02 CAN THE TIME INTERVAL BETWEEN MRI AND FUSION BIOPSY AFFECT THE CANCER DETECTION RATES? (2019) (0)
- A prospective trial assessing the effects of clamp ischemia during partial nephrectomy on renal function, biomarkers, and structure. (2012) (0)
- NAD(P)H OXIDASE SUBUNIT P22PHOX MEDIATES HYPOXIA-INDUCIBLE FACTOR-2-ALPHA TRANSCRIPTIONAL ACTIVITY AND IS OVER-EXPRESSED IN HUMAN RENAL CELL CARCINOMA (2009) (0)
- MP09-01 GENOMIC HETEROGENEITY IN TISSUE-BASED PROGNOSTIC SIGNATURES FROM PROSTATE BIOPSIES; RESULTS FROM TWO PROSPECTIVE TRIALS (2020) (0)
- Editorial Comment. (2016) (0)
- Partial Penectomy (2019) (0)
- 335 Nutritional status and major abdominal surgeries: 30-Day postoperative complications (2016) (0)
- Evaluation of High-Intensity Focused Ultrasound (HIFU) for Treatment of Localized Prostate Cancer (2020) (0)
- MP59-15 PERIOPERATIVE AND FUNCTIONAL OUTCOMES OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR RENAL TUMORS >4 CM IN A MULTI-INSTITUTIONAL, MULTI-NATIONAL COHORT (2015) (0)
- 384 REDUCED EXPRESSION OF FUMARATE HYDRATASE IN CLEAR CELL RENAL CANCER PROMOTES HIF-2α ACCUMULATION, MIGRATION AND INVASION (2011) (0)
- 3:48 PM Abstract No. 9 Prostate artery embolization for prostate volumes ≥ 80g vs. <80g - clinical outcomes from a single institution (2018) (0)
- MP16-20 PREDICTORS OF DISCHARGE TO HOME FOLLOWING MAJOR SURGERY FOR UROLOGIC MALIGNANCIES (2022) (0)
- MP53-20 CAN PSA DENSITY AND FREE-TO-TOTAL PSA RATIO IMPROVE OUR ABILITY TO PREDICT PROSTATE CANCER ON BIOPSY? RESULTS FROM A PROSPECTIVE, MULTI-INSTITUTIONAL, AND CONTEMPORARY COHORT (2016) (0)
- Editorial comment on END-2019-0226-I-RE.R1. (2019) (0)
- Comparison of survival outcomes for African American and Caucasian men with advanced penile cancer in Florida. (2016) (0)
- PD08-09 PREDIAGNOSTIC PROSTATE-SPECIFIC ANTIGEN KINETICS ARE NOT ASSOCIATED WITH THE RISK OF PROGRESSION IN PROSTATE CANCER PATIENTS MANAGED WITH ACTIVE SURVEILLANCE (2016) (0)
- PD50-10 ESTABLISHING THE BEST THRESHOLD FOR BIOPSY IN MPMRI NEGATIVE OR INDETERMINATE USING DATA FROM A LARGE MULTI-INSTITUTIONAL COHORT OF MEN UNDERGOING MPMRI, 4KSCORE AND PROSTATE BIOPSY (2021) (0)
- Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017 (2021) (0)
- Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging (2023) (0)
- MP32-20 PREDICTORS OF POSTOPERATIVE HEALTH-RELATED QUALITY OF LIFE (HRQOL): AN ANALYSIS FROM THE RAZOR TRIAL (2019) (0)
- MP40-15 DOES MRI PERFORM DIFFERENTLY IN MEN UNDERGOING TARGETED BIOPSY FOR EVALUATION OF PROSTATE CANCER VERSUS THOSE ON ACTIVE SURVEILLANCE? (2018) (0)
- S12 Chemoprevention of prostate cancer – the role of 5 alpha reductase inhibitors (2010) (0)
- 987: Optical Spectroscopy in Differentiating Benign and Malignant Renal Tissues : A Potentially Useful Modality (2004) (0)
- Traumatic Fetal Decapitation After Spontaneous Abortion: An Extremely Rare Occurrence (2015) (0)
- Genomic Heterogeneity in Prognostic Signatures from Prostate Biopsies: Results from Two Prospective Trials (2020) (0)
- MP24-09 SURVEILLANCE INTENSITY AND DETECTION OF RECURRENCE AND PROGRESSION IN INTERMEDIATE RISK NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) (2020) (0)
- Department of Error (2014) (0)
- Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysis (2021) (0)
This paper list is powered by the following services:
Other Resources About Dipen J Parekh
What Schools Are Affiliated With Dipen J Parekh?
Dipen J Parekh is affiliated with the following schools:
